Article

Evaluation and comparison of different breast cancer prognosis scores based on gene expression data

2022-07-06

Abstract excerpt

<h4>Background: </h4> Breast cancer is one of the three most common cancers worldwide and is the most common malignancy in women. Treatment approaches for breast cancer are diverse and varied. Clinicians must balance risks and benefits when deciding treatments, and models have been developed to support this decision-making. Genomic risk scores (GRS) may offer greater clinical value than standard clinicopathologica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd637d1a-b880-57d1-9b5b-2442cad8ffc1
DOI: 10.21203/rs.3.rs-1795334/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation and comparison of different breast cancer prognosis scores based on gene expression dataDOI 10.21203/rs.3.rs-1795334/v1Read

Evaluation and comparison of different breast cancer prognosis scores based on gene expression dataSemantic proximity Read

Devising Breast Cancer Diagnosis Protocol through Machine LearningSemantic proximity Read

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score.Semantic proximity Read

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.Semantic proximity Read

High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity Read

Estimated survival outcomes and absolute chemotherapy treatment benefit using PREDICT Tool® and EndoPredict®, in hormone-positive early-stage breast cancer.Semantic proximity Read

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.Semantic proximity Read

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity Read

Genomic Machine Learning Model Predicts Radiation Therapy Benefit in Early-Stage Breast Cancer Patients with High AccuracySemantic proximity Read

Predictive Value of Immune Genomic Signatures from Breast Cancer Cohorts Containing Data for Both Response to Neoadjuvant Chemotherapy and Prognosis after SurgerySemantic proximity Read

Clinical Validation of RlapsRisk BC in an international multi-cohorts settingSemantic proximity Read

A Framework to Predict the Applicability of Gene Signatures for Improving Prognostic PredictionSemantic proximity Read